Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes

NCT ID: NCT02008591

Last Updated: 2017-01-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-26

Study Completion Date

2016-01-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief.

The secondary objective of this study is to compare the fetal effects of these three epidural labor analgesia techniques.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laboring Women Requesting Neuraxial Labor Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized controlled trial with computer generated (Microsoft Excel 2015) assignment placed in sealed envelopes.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Anesthesiologist performing technique and bedside nurse instructed not to reveal randomization arm to the patient or study co-investigator who was waiting outside the room, and notified only after completion of the neuraxial placement protocol.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epidural Technique

Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min

Group Type ACTIVE_COMPARATOR

Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique

Intervention Type PROCEDURE

Three different techniques, using the same medications (bupivacaine and fentanyl)

Combined Spinal Epidural Technique

Bupivacaine 2.5 mg with Fentanyl 25 mcg

Group Type ACTIVE_COMPARATOR

Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique

Intervention Type PROCEDURE

Three different techniques, using the same medications (bupivacaine and fentanyl)

Dural Puncture Epidural Technique

Bupivacaine 0.125% with Fentanyl 2 mcg/mL, 15 mL load over 5 min

Group Type ACTIVE_COMPARATOR

Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique

Intervention Type PROCEDURE

Three different techniques, using the same medications (bupivacaine and fentanyl)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique

Three different techniques, using the same medications (bupivacaine and fentanyl)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\. Nulliparous (first baby) parturient 2. Singleton, vertex gestation at term (37-42 weeks) 3. Less than 5 cm dilation 4. Desires an epidural technique for labor analgesia

Exclusion Criteria

\- 1. Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes) 2. Any contraindication to the administration of an epidural technique 3. History of hypersensitivity or idiosyncratic reaction to local anesthetic or opioid medications 4. Current or historical evidence of a disease which may result in the risk of a cesarean delivery.

5\. Evidence of anticipated fetal anomalies
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brigham and Women's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lawrence Ching Tsen

Associate Professor, Harvard Medical School

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lawrence C Tsen, MD

Role: PRINCIPAL_INVESTIGATOR

Brigham and Women's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013P001927

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.